Mineralys Therapeutics, Inc. Common Stock (MLYS) — Financial Flexibility Index
Mineralys Therapeutics, Inc. Common Stock (MLYS) has a Financial Flexibility Index of -0.28x as of June 2026. Free cash flow of $-32.56 Million (operating CF $-32.56 Million minus capex $0.00) represents 0% of total liabilities ($116.94 Million). Check how tangible is Mineralys Therapeutics, Inc. Common Stoc's equity to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Mineralys Therapeutics, Inc. Common Stock Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for Mineralys Therapeutics, Inc. Common Stock across 6 annual periods. For the full cash flow conversion analysis, see MLYS cash generation efficiency.
Annual Financial Flexibility Index for Mineralys Therapeutics, Inc. Common Stock (2020–2025)
Year-by-year free cash flow to debt coverage for Mineralys Therapeutics, Inc. Common Stock. Explore MLYS operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -9.42x | $-142.40 Million | $-142.42 Million | $15.11 Million | ▲ +17.0% |
| 2024 | -11.35x | $-166.22 Million | $-166.31 Million | $14.65 Million | ▼ -46.6% |
| 2023 | -7.74x | $-81.17 Million | $-81.17 Million | $10.48 Million | ▼ -4318.1% |
| 2022 | -0.18x | $-29.22 Million | $-29.22 Million | $166.71 Million | ▲ +59.0% |
| 2021 | -0.43x | $-14.56 Million | $-14.56 Million | $34.05 Million | ▲ +11.8% |
| 2020 | -0.48x | $-2.46 Million | $-2.46 Million | $5.08 Million | — |